A detailed history of Acuitas Investments, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Acuitas Investments, LLC holds 40,261 shares of LGND stock, worth $4.49 Million. This represents 1.93% of its overall portfolio holdings.

Number of Shares
40,261
Previous 54,682 26.37%
Holding current value
$4.49 Million
Previous $4.61 Million 12.48%
% of portfolio
1.93%
Previous 2.6%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$82.7 - $110.11 $1.19 Million - $1.59 Million
-14,421 Reduced 26.37%
40,261 $4.03 Million
Q1 2024

May 10, 2024

BUY
$68.64 - $89.2 $479,038 - $622,526
6,979 Added 14.63%
54,682 $4 Million
Q4 2023

Feb 02, 2024

BUY
$49.57 - $72.63 $2.36 Million - $3.46 Million
47,703 New
47,703 $3.41 Million

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.88B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Acuitas Investments, LLC Portfolio

Follow Acuitas Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuitas Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuitas Investments, LLC with notifications on news.